Science Applications International (SAIC) Wins Fresh CBP Work, Is The Stock Above Fair Value?

Science Applications International (SAIC) just secured a fresh catalyst, winning a $742 million recompete task order with U.S. Customs and Border Protection, alongside a separate $199 million contract tied to traveler screening systems.

The fresh CBP awards land at a time when Science Applications International’s share price has already been moving higher, with a 1-day share price return of 6.25% taking the stock to $129.71 and adding to a 90-day share price return of 15.17% and a 1-year total shareholder return of 33.88%. Together, these figures indicate momentum building as investors reassess both growth prospects and risk around the contract pipeline.

Spot similar contract driven momentum across government IT and defense services by scanning our hand picked list of solid balance sheet and fundamentals (25 results), which could sit beside Science Applications International in your watchlist.

Science Applications International now trades higher after the contract news, and the move could signal confidence in the underlying cash engine as much as it does a mood shift around federal IT spending. So what does the valuation actually imply?

Most Popular Narrative: 9% Overvalued

On the numbers alone, the most followed narrative pegs Science Applications International’s fair value at $119.24, which sits below the latest $129.71 close and frames the fresh CBP wins against a stock that some investors already see as priced ahead of that estimate.

The ORBIT launch in August was the dominant communication event of the call, and it was managed as one. Reagan devoted a substantial portion of prepared remarks to ORBIT mechanics (procurement, recruiting, agentic AI in mission delivery), followed by Natarajan's financial architecture (six themes, margin trajectory, reinvestment split). Three separate Q&A exchanges extended the ORBIT discussion further. The deliberate volume of ORBIT communication had the effect of anchoring analyst attention to the transformation program's promise while the book-to-bill miss occupied comparatively little real estate.

See why 2 investors see Science Applications International as 9% overvalued.

Result: Fair Value of $119.24 (OVERVALUED)

Still, the softer book to bill and lower submission volume described in the recent Science Applications International call could pressure the narrative around the contract pipeline.

Find out about the key risks to this Science Applications International narrative.

Another View: Science Applications International Through Earnings Ratios

The fair value narrative around Science Applications International looks very different when you swap the story-driven estimate for simple earnings ratios. At a P/E of 14.3x, the stock trades below the fair ratio of 16x, and also below both peer averages at 22.5x and the wider US Professional Services group at 21.5x. That kind of gap can indicate either a valuation cushion if the business delivers, or a market signal that future progress carries meaningful risk.

For investors who prefer to let comparative metrics lead, the key question is whether this discount reflects compensation for execution questions around bookings and debt, or represents an opening that could narrow if sentiment shifts toward companies with high quality earnings and strong return on equity.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed messages in the Science Applications International story so far, with fresh contracts and valuation questions pulling in opposite directions, mean the real edge comes from doing your own homework quickly and weighing both risks and potential upside using the full picture in 3 key rewards and 1 important warning sign.

Looking for more Science Applications International style ideas?

Do not stop at Science Applications International. Broaden your watchlist with other potential opportunities so you are not relying on a single contract driven story.

• Spot potential bargains by scanning companies that combine quality fundamentals with discounted valuations through the 27 high quality undervalued stocks.
• Strengthen your income stream by reviewing stocks with robust payouts and yields in the 8 dividend fortresses.
• Sleep easier by focusing on businesses that pair solid balance sheets with resilient fundamentals using the list of solid balance sheet and fundamentals (25 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com